Remove Equities Remove IPO Remove Webinar
article thumbnail

Highlights from Cooley’s M&A Dealmakers Roundtable: SPACs!

Cooley M&A

On September 24, Cooley M&A partner, Garth Osterman, moderated a webinar on the current trend in going public: SPACs! Key highlights from the webinar are summarized below and a link to the recording can be found here. is the increased frequency at which SPAC IPOs are occurring. A distinct feature of SPAC 3.0

M&A 52
article thumbnail

C Corp vs. S Corp vs. LLC: Essential Information for Software Executives

Software Equity Group

C Corp for Software Companies Factor Impact Investor Appeal Tax Efficiency Ownership Flexibility M&A Potential C Corps are highly attractive to investors, particularly for those considering venture capital or IPO. The flexibility to have multiple stock classes is a major draw for institutional investors.

M&A 52
article thumbnail

Cooley’s 2020 Life Sciences M&A Year in Review

Cooley M&A

The initial offer for €39 per share was not well received by Qiagen shareholders, who believed that Qiagen’s equity was worth substantially more than the offered price due to the company’s involvement in the development of COVID-19 tests and related products. Life Sciences Enters the SPAC Party, But Will Reverse Merger Suitors Join In?

M&A 40